|
ADVM Adverum Biotechnologies Inc 1501756 |
| Balance Sheet |
|
Current Assets
|
161,080,000 |
|
Assets
|
234,375,000 |
|
Current Liabilities
|
27,657,000 |
|
Liabilities
|
90,259,000 |
|
Equity
|
144,116,000 |
|
Shares Out
|
20,801,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-64,213,000 |
|
Investing Cash Flow
|
-37,700,000 |
| Market Analysis |
Market Cap
|
156,422,692 |
|
Price
|
5.63 |
|
BVPS
|
6.93 |
|
PB
|
0.75 |
|
EPS
|
-7.99 |
|
PS
|
39.11 |
|
FCF
|
-101,913,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view ADVM documents filed with the SEC.
ADVM Filings
Clear
